The receptor tyrosine kinase HER2 is overexpressed in around 20% of breast cancers. Here we show HER2 dimerisation with HER3 in ligand-induced as well as drug-induced orientations. For more information, read the full paper here: https://elifesciences.org/articles/32271
Keywords: Design, 3D, Editorial, Research, Cell biology / Histology, Molecular Biology, Oncology
© Phospho
